Immunity 2014

Shiitake-mycelium-fermented rice bran (RBEP) in healthy adults: raised IFN-γ production (randomized double-blind placebo-controlled, n=80)

The Choi et al. RCT (South Korea, 2014): 80 healthy adults took 3 g/day of RBEP (an exo-biopolymer from shiitake-mycelium-fermented rice bran) or placebo for 8 weeks. Serum IFN-γ rose significantly with no changes in NK activity or other cytokines. Supports the immuno-adjuvant hypothesis for shiitake polysaccharides via a Th1 cytokine profile, but an NK-cell effect was not confirmed in this sample.

Choi J.Y., Paik D.J., Kwon D.Y., Park Y. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study. Nutrition Journal. 2014;13:35.

Rationale

Fermenting rice bran with shiitake mycelium yields an exo-biopolymer (RBEP) designed to be an oral immune adjuvant; this trial measured its cytokine and NK-cell effects in humans.

Methods

A randomized double-blind placebo-controlled parallel study: 80 healthy adults with leukocyte counts 4000–8000/µL took 3 g/day RBEP or placebo for 8 weeks, measuring serum cytokines including IFN-γ and NK-cell activity.

Results

Serum IFN-γ increased significantly in the RBEP group; NK activity and other cytokines did not change.

Conclusions

RBEP shifted a Th1-polarity cytokine upward — supporting an immune-adjuvant mechanism — while the NK-cell effect seen in other shiitake work did not replicate here.

Worth noting

The honest split — IFN-γ yes, NK no — matters more than either half alone: the immunomodulation is specific, not global. A fermented-bran product is a different material from mushroom powder or extract; RBEP results do not generalize to culinary shiitake.